| Glycerol kinase 5 confers gefitinib resistance through SREBP1/SCD1 signaling pathway | |
| Hu, Jie; Zhou, Jian; Qu, Guimei; Zhang, Ge; Wu, Zuoren; Liu, Jing; Yang, Dawei; Li, Jing; Chang, Meijia; Zeng, Hengshan | |
| 刊名 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
 |
| 2019 | |
| 卷号 | 38 |
| 关键词 | Non-small cell lung cancer Glycerol kinase 5 Gefitinib Stearoyl-CoA desaturase-1 |
| ISSN号 | 1756-9966 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3598063 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Hu, Jie,Zhou, Jian,Qu, Guimei,et al. Glycerol kinase 5 confers gefitinib resistance through SREBP1/SCD1 signaling pathway[J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,2019,38. |
| APA | Hu, Jie.,Zhou, Jian.,Qu, Guimei.,Zhang, Ge.,Wu, Zuoren.,...&Bai, Chunxue.(2019).Glycerol kinase 5 confers gefitinib resistance through SREBP1/SCD1 signaling pathway.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,38. |
| MLA | Hu, Jie,et al."Glycerol kinase 5 confers gefitinib resistance through SREBP1/SCD1 signaling pathway".JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 38(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论